Retroperitoneal Fibrosis: Evolving Concepts

Rheumatic Disease Clinics of North America

Volumn 33, Issue 4, 2007, Pages 803-817

  Vaglio, Augusto ^a   Palmisano, Alessandra ^a   Corradi, Domenico ^a   Salvarani, Carlo ^b   Buzio, Carlo ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Servizio di Reumatologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TAMOXIFEN;

ABDOMINAL AORTA; ANOREXIA; CLAUDICATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EDEMA; ERECTILE DYSFUNCTION; FATIGUE; FEVER; HUMAN; HYDROCELE; IDIOPATHIC DISEASE; ILIAC ARTERY; IMMUNOGENETICS; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; LABORATORY TEST; LOW BACK PAIN; NEPHROSTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGURIA; PATHOPHYSIOLOGY; POLYURIA; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RELAPSE; RETROPERITONEAL FIBROSIS; REVIEW; SCROTAL PAIN; URETER STENT; VARICOCELE; VASCULITIS; WEIGHT REDUCTION;

DIAGNOSIS, DIFFERENTIAL; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; PROGNOSIS; RETROPERITONEAL FIBROSIS;

EID: 36248993397     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.07.013     Document Type: Review

References (54)

1. Vaglio A., Salvarani C., and Buzio C. Retroperitoneal fibrosis. Lancet 367 9506 (2006) 241-251
2. Mitchinson M.J. The pathology of idiopathic retroperitoneal fibrosis. J Clin Pathol 23 8 (1970) 681-689
3. Koep L., and Zuidema G.D. The clinical significance of retroperitoneal fibrosis. Surgery 81 3 (1977) 250-257
4. Hughes D., and Buckley P.J. Idiopathic retroperitoneal fibrosis is a macrophage-rich process. Implications for its pathogenesis and treatment. Am J Surg Pathol 17 5 (1993) 482-490
5. Vaglio A., Corradi D., Manenti L., et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 114 6 (2003) 454-462
6. Martorana D., Vaglio A., Greco P., et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 55 1 (2006) 126-130
7. Vaglio A., Greco P., Corradi D., et al. Autoimmune aspects of chronic periaortitis. Autoimmun Rev 5 7 (2006) 458-464
8. Wu J., Catalano E., and Coppola D. Retroperitoneal fibrosis (Ormond's disease): clinical pathologic study of eight cases. Cancer Control 9 5 (2002) 432-437
9. Parums D.V. The spectrum of chronic periaortitis. Histopathology 16 5 (1990) 423-431
10. Serra R.M., Engle J.E., Jones R.E., et al. Perianeurysmal retroperitoneal fibrosis. An unusual cause of renal failure. Am J Med 68 1 (1980) 149-153
11. Vaglio A., and Buzio C. Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 17 1 (2005) 34-40
12. Ohara H., Nakazawa T., Ando T., et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J Gastroenterol 42 Suppl 18 (2007) 15-21
13. Okada H., Takahira S., Sugahara S., et al. Retroperitoneal fibrosis and systemic lupus erythematosus. Nephrol Dial Transplant 14 5 (1999) 1300-1302
14. Demko T.M., Diamond J.R., and Groff J. Obstructive nephropathy as a result of retroperitoneal fibrosis: a review of its pathogenesis and associations. J Am Soc Nephrol 8 4 (1997) 684-688
15. Kamisawa T., Funata N., Hayashi Y., et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 52 5 (2003) 683-687
16. Hamano H., Kawa S., Ochi Y., et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 359 9315 (2002) 1403-1404
17. Neild G.H., Rodriguez-Justo M., Wall C., et al. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 4 (2006) 23
18. Uibu T., Oksa P., Auvinen A., et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet 363 9419 (2004) 1422-1426
19. Gilkeson G.S., and Allen N.B. Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am 22 1 (1996) 23-38
20. Rasmussen T.E., Hallett Jr. J.W., Metzger R.L., et al. Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element. J Vasc Surg 25 2 (1997) 356-364
21. Jois R.N., Gaffney K., Marshall T., et al. Chronic periaortitis. Rheumatology (Oxford) 43 11 (2004) 1441-1446
22. van Bommel E.F., Siemes C., Hak L.E., et al. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 49 5 (2007) 615-625
23. Kardar A.H., Kattan S., Lindstedt E., et al. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 168 2 (2002) 550-555
24. Vaglio A., Manenti L., Allegri L., et al. ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis?. J Intern Med 251 3 (2002) 268-271
25. Izzedine H., Servais A., Launay-Vacher V., et al. Retroperitoneal fibrosis due to Wegener's granulomatosis: a misdiagnosis as tuberculosis. Am J Med 113 2 (2002) 164-166
26. Mavragani C.P., and Voulgarelis M. Retroperitoneal fibrosis and c-ANCA positivity. Clin Rheumatol 26 1 (2007) 115-116
27. Armigliato M., Paolini R., Bianchini E., et al. Hashimoto's thyroiditis and Graves' disease associated with retroperitoneal fibrosis. Thyroid 12 9 (2002) 829-831
28. Ghinoi A., Pipitone N., Boiardi L., et al. Primary Sjogren's syndrome associated with chronic periaortitis. Rheumatology (Oxford) 46 4 (2007) 719-720
29. Corradi D., Maestri R., Palmisano A., et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int (2007) [epub ahead of print]
30. Mitchinson M.J. Chronic periaortitis and periarteritis. Histopathology 8 4 (1984) 589-600
31. Greco P., Vaglio A., Corradi D., et al. Tuberculosis as a trigger of retroperitoneal fibrosis. Clin Infect Dis 41 7 (2005) e72-e75
32. Parums D.V., Brown D.L., and Mitchinson M.J. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 114 4 (1990) 383-387
33. Parums D.V., Chadwick D.R., and Mitchinson M.J. The localisation of immunoglobulin in chronic periaortitis. Atherosclerosis 61 2 (1986) 117-123
34. Miller O.F., Smith L.J., Ferrara E.X., et al. Presentation of idiopathic retroperitoneal fibrosis in the pediatric population. J Pediatr Surg 38 11 (2003) 1685-1688
35. Yonemitsu Y., Nakagawa K., Tanaka S., et al. In situ detection of frequent and active infection of human cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction. Lab Invest 74 4 (1996) 723-736
36. Chizzolini C., Raschi E., Rezzonico R., et al. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 46 6 (2002) 1602-1613
37. Salvarani C., Pipitone N., Versari A., et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 53 2 (2005) 298-303
38. Vanoli M., Daina E., Salvarani C., et al. Takayasu's arteritis: a study of 104 Italian patients. Arthritis Rheum 53 1 (2005) 100-107
39. Ramshaw A.L., Roskell D.E., and Parums D.V. Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol 47 8 (1994) 721-727
40. Moroni G., Del Papa N., Moronetti L.M., et al. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease. Kidney Int 68 2 (2005) 562-568
41. Hamano H., Kawa S., Horiuchi A., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344 10 (2001) 732-738
42. Veyssier-Belot C., Cacoub P., Caparros-Lefebvre D., et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 75 3 (1996) 157-169
43. Kottra J.J., and Dunnick N.R. Retroperitoneal fibrosis. Radiol Clin North Am 34 6 (1996) 1259-1275
44. Vivas I., Nicolas A.I., Velazquez P., et al. Retroperitoneal fibrosis: typical and atypical manifestations. Br J Radiol 73 866 (2000) 214-222
45. Blockmans D. The use of (18F)fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 21 Suppl 32 (2003) S15-S22
46. Vaglio A., Versari A., Fraternali A., et al. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis. Arthritis Rheum 53 1 (2005) 122-125
47. Drieskens O., Blockmans D., Van den Bruel A., et al. Riedel's thyroiditis and retroperitoneal fibrosis in multifocal fibrosclerosis: positron emission tomographic findings. Clin Nucl Med 27 6 (2002) 413-415
48. Arrive L., Hricak H., Tavares N.J., et al. Malignant versus nonmalignant retroperitoneal fibrosis: differentiation with MR imaging. Radiology 172 1 (1989) 139-143
49. Pickhardt P.J., and Bhalla S. Unusual nonneoplastic peritoneal and subperitoneal conditions: CT findings. Radiographics 25 3 (2005) 719-730
50. Baker L.R., Mallinson W.J., Gregory M.C., et al. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 60 6 (1987) 497-503
51. Marcolongo R., Tavolini I.M., Laveder F., et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 116 3 (2004) 194-197
52. Jois R.N., Kerrigan N., and Scott D.G. Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis. Rheumatology (Oxford) 46 4 (2007) 717-718
53. Scheel Jr. P.J., Piccini J., Rahman M.H., et al. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol 178 1 (2007) 140-143 [discussion: 143-4]
54. van Bommel E.F., Hendriksz T.R., Huiskes A.W., et al. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med 144 2 (2006) 101-106